These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 37454742)

  • 1. Deep learning in preclinical antibody drug discovery and development.
    Zhou Y; Huang Z; Li W; Wei J; Jiang Q; Yang W; Huang J
    Methods; 2023 Oct; 218():57-71. PubMed ID: 37454742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Progress of Deep Learning in Drug Discovery.
    Wang F; Diao X; Chang S; Xu L
    Curr Pharm Des; 2021; 27(17):2088-2096. PubMed ID: 33511933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications.
    Sumathi S; Suganya K; Swathi K; Sudha B; Poornima A; Varghese CA; Aswathy R
    Curr Pharm Des; 2023 May; 29(13):1013-1025. PubMed ID: 37055908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerating antibody discovery and design with artificial intelligence: Recent advances and prospects.
    Bai G; Sun C; Guo Z; Wang Y; Zeng X; Su Y; Zhao Q; Ma B
    Semin Cancer Biol; 2023 Oct; 95():13-24. PubMed ID: 37355214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation.
    Koutroumpa NM; Papavasileiou KD; Papadiamantis AG; Melagraki G; Afantitis A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery.
    Wilman W; Wróbel S; Bielska W; Deszynski P; Dudzic P; Jaszczyszyn I; Kaniewski J; Młokosiewicz J; Rouyan A; Satława T; Kumar S; Greiff V; Krawczyk K
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35830864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.
    Jing Y; Bian Y; Hu Z; Wang L; Xie XQ
    AAPS J; 2018 Mar; 20(3):58. PubMed ID: 29603063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents.
    Kashyap K; Siddiqi MI
    Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry.
    Kumar SA; Ananda Kumar TD; Beeraka NM; Pujar GV; Singh M; Narayana Akshatha HS; Bhagyalalitha M
    Future Med Chem; 2022 Feb; 14(4):245-270. PubMed ID: 34939433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The applications of deep learning algorithms on in silico druggable proteins identification.
    Yu L; Xue L; Liu F; Li Y; Jing R; Luo J
    J Adv Res; 2022 Nov; 41():219-231. PubMed ID: 36328750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep learning in image-based phenotypic drug discovery.
    Krentzel D; Shorte SL; Zimmer C
    Trends Cell Biol; 2023 Jul; 33(7):538-554. PubMed ID: 36623998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases.
    Muller C; Rabal O; Diaz Gonzalez C
    Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction.
    Lin X; Dai L; Zhou Y; Yu ZG; Zhang W; Shi JY; Cao DS; Zeng L; Chen H; Song B; Yu PS; Zeng X
    Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37401373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New avenues in artificial-intelligence-assisted drug discovery.
    Cerchia C; Lavecchia A
    Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing preclinical drug discovery with artificial intelligence.
    Vijayan RSK; Kihlberg J; Cross JB; Poongavanam V
    Drug Discov Today; 2022 Apr; 27(4):967-984. PubMed ID: 34838731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Drug Discovery with Deep Learning.
    Özçelik R; van Tilborg D; Jiménez-Luna J; Grisoni F
    Chembiochem; 2023 Jul; 24(13):e202200776. PubMed ID: 37014633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of deep learning algorithms in drug discovery.
    Piroozmand F; Mohammadipanah F; Sajedi H
    Chem Biol Drug Des; 2020 Sep; 96(3):886-901. PubMed ID: 33058458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How can we discover developable antibody-based biotherapeutics?
    Bauer J; Rajagopal N; Gupta P; Gupta P; Nixon AE; Kumar S
    Front Mol Biosci; 2023; 10():1221626. PubMed ID: 37609373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.